City
Epaper

WHO releases 1st-ever guidance on clinical management of diphtheria

By IANS | Updated: February 15, 2024 12:05 IST

Geneva, Feb 15 In a first, the World Health Organization (WHO) has released guidance on the clinical management ...

Open in App

Geneva, Feb 15 In a first, the World Health Organization (WHO) has released guidance on the clinical management of diphtheria.

While previous available guidance was just an operational protocol, the new guidance followed the rigorous process for developing guidance at WHO.

It addresses the use of Diphtheria Antitoxin (DAT) in the treatment of diphtheria.

The guidance also includes new recommendations on antibiotics. In patients with suspected or confirmed diphtheria, WHO recommends using macrolide antibiotics (azithromycin, erythromycin) rather than penicillin antibiotics.

“This clinical practice guideline has been rapidly developed recognising the global increase in diphtheria outbreaks. Outbreaks of diphtheria in Nigeria, Guinea and neighbouring countries in 2023 have highlighted the urgent need for evidence-based clinical practice guidelines for the treatment of diphtheria,” the WHO said.

“Given the sporadic nature of outbreaks, many clinicians in the affected regions have never managed acute diphtheria and its related complications. Diphtheria remains a neglected disease and vaccination is the top priority. At the same time, for patients with diphtheria, access to antibiotics, DAT and supportive care can be lifesaving,” the agency noted.

Diphtheria is a disease caused by a bacterium that affects the upper respiratory tract and less often the skin. It also produces a toxin that damages the heart and the nerves.

It is a vaccine preventable disease, but multiple doses and booster doses are needed to produce and sustain immunity. People who are not immunised or under immunised are at risk of the disease.

Diphtheria is fatal in 5-10 per cent of cases, with a higher mortality rate in young children.

Recent diphtheria outbreaks stress the importance of sustaining high levels of vaccination coverage in communities across the life course.

In 2022, an estimated 84 per cent of children worldwide received the recommended 3 doses of diphtheria-containing vaccine during infancy, leaving 16 per cent with no or incomplete coverage. There is wide coverage variation between and within countries.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

MaharashtraLadki Bahin Yojana: Rs 4,800 Crore Scam Exposed, Supriya Sule Drops Bombshell — How Did Men Receive Benefits?

BusinessAll India Institute of Occult Science Successfully Holds its 21st Convocation Ceremony in New Delhi

Other Sports'Historic win': Sachin Tendulkar hails Divya Deshmukh on winning India's first Women's WC

EntertainmentAditya Kumar calls playing a man from his early 20s to his 70s in ‘Chimni’ a challenging opportunity

TechnologyFinancial discipline drives momentum in Indian real estate sector, bank credit surges: Report

Health Realted Stories

HealthMeasles death toll climbs to 10 in Mongolia

HealthORS affordable, effective healthcare solution for dehydration & diarrhoea: Nadda

HealthEating chips, cookies can raise addiction risk akin to substance-use disorders: Study

HealthMore than 673 million people worldwide experienced hunger in 2024: UN report

HealthKerala HC accepts proposal to set up interim committee to curb stray dog attacks